tag genetic-data 
Pharmaceutical Technology
MAY 1, 2023
CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Additionally, both the companies will share CTH-004 pre-clinical and clinical data in future.
Pharmaceutical Technology
MAY 2, 2023
Chimeric antigen receptor T-cell (CAR-T) therapies are the only genetically modified cell therapies to have received regulatory approval, and they are currently utilised in relapsed/refractory settings. Combining data from all markets, efficacy-related needs were identified as the most important unmet needs category.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Celeritas
NOVEMBER 7, 2022
It uses advanced sensor systems to collect data and then assesses that data to identify the ideal combination of inputs and systems. SLF focuses on data capture and analysis to maximize productivity and efficiency; PLF relies on precise measurements and precise application to accomplish the same goal. Satellite-based monitoring.
pharmaphorum
DECEMBER 23, 2022
Here, Richard Staines reports on phase I/II data unveiled at the American Society of Hematology conference that supports further clinical development of inobrodib in multiple myeloma and other blood cancers. Oral therapy data presented at ASH. Oral therapy data presented at ASH. CellCentric, a U.K-based
pharmaphorum
AUGUST 18, 2022
An FDA advisory committee recommended approval of Zynteglo on the strength of that data in June. Zynteglo is a customised, one-time treatment created using a patient’s own bone marrow stem cells hat are genetically modified to produce functional beta-globin, which is mutated in the disease. million, which compares to the $1.7
Pharmaceutical Technology
JULY 14, 2022
It is estimated that there are currently more than 7,000 orphan diseases, many of which are considered life-threatening and most of which have a genetic basis. These countries will have a smaller patient pool due to population size and will likely carry a price tag that is significantly below that of higher GDP countries.”.
Clarify Health
JULY 13, 2021
Bringing the same analytics technology used by leading banks and retailers like JPMorgan and Amazon , together with data from the Centers for Medicare Services (CMS) and electronic health records, reveals a fascinating new picture of the quality, resource effectiveness, and practice patterns of individual physicians and hospitals.
Expert insights. Personalized for you.
52 
Let's personalize your content